No Data
No Data
No Data
CHARMACY PHAR To Go Ex-Dividend On May 22nd, 2024 With 0.32977 HKD Dividend Per Share
May 22nd - $CHARMACY PHAR(02289.HK)$ is trading ex-dividend on May 22nd, 2024. Shareholders of record on May 23rd, 2024 will receive 0.32977 HKD dividend per share on July 10th, 2024. The ex-divid
Charmacy Pharmaceutical to Pay Final Dividend
Charmacy Pharmaceutical (HKG:2289) will pay a final dividend of 0.3 yuan per share for the year ended Dec. 31, 2023, according to a Monday filing on the Hong Kong bourse. The record date is June 7, an
Chuangmei Pharmaceutical (02289.HK): Zheng Xiyue was elected as the employee representative supervisor of the Supervisory Board
Gelonghui, May 20, 丨 Chuangmei Pharmaceutical (02289.HK) announced that Zheng Xiyue was elected as the employee representative supervisor of the fourth board of supervisors at the company's employee congress held on May 20, 2024. He and the shareholder representative supervisors and independent supervisors of the 4th board of supervisors elected by the company on May 20, 2024 (“Annual General Meeting of Shareholders”) will form the fourth board of supervisors of the company.
CHARMACY PHAR: POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 20 MAY 2024; AND DISTRIBUTION OF THE 2023 FINAL DIVIDEND
A record high! The total number of clinical trials exceeded 4,000 in 2023
According to the report, in 2023, the total number of clinical trials registered on the drug clinical trial registration and information disclosure platform surpassed 4,000 for the first time, reaching 4,300 (in terms of CTR), the highest total number of registrations in history, an increase of 26.1% over the total number of registrations in 2022.
This Is Why Charmacy Pharmaceutical Co., Ltd.'s (HKG:2289) CEO Can Expect A Bump Up In Their Pay Packet
Key Insights Charmacy Pharmaceutical's Annual General Meeting to take place on 20th of May Total pay for CEO Chuanglong Yao includes CN¥636.3k salary The overall pay is 47% below the industry aver
No Data